3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Subarachnoid Hemorrhage
1
Seizures
1
Meningitis
1
Ischemic Stroke
1
Heart Arrest
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Interventions
Levetiracetam
6
Cannabidiol
4
perampanel
2
Standard of Care
2
Everolimus
2
enzalutamide
1
Vigabatrin
1
Tranexamic Acid
1
Temozolomide
1
Sodium Chloride
1
Saline Solution
1
Pregabalin
1
Medical Marijuana
1
Magnesium Sulfate
1
Drug Therapy
1
Curcumin
1
Cholecalciferol
1
Aspirin
1
Anticonvulsants
1
Anastrozole
1
Airway Extubation
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Seizures
×
Airway Extubation
×
Clear all
NCT02920580
2020-02-05
NEURO-ETT
Sunnybrook Health Sciences Centre
Phase NA
Unknown
27 enrolled